期刊文献+

儿童下呼吸道感染病原菌分布及耐药性分析 被引量:20

Distribution and drug resistance of pathogens causing lower respiratory tract infections in children
原文传递
导出
摘要 目的研究儿童下呼吸道感染病原菌分布特点及耐药性,为临床用药提供依据,指导临床合理使用抗菌药物。方法回顾性分析医院2008年1月-2012年12月3 684例下呼吸道感染住院患儿的痰培养及药敏试验结果,采用VITEK-2全自动微生物鉴定仪及药敏卡进行细菌鉴定及药敏试验,采用WHONET5.4微生物实验室数据处理软件对研究数据进行统计分析。结果 3 684例下呼吸道感染患儿痰培养阳性943例,阳性率为25.6%,检出革兰阴性杆菌596株占63.2%,以铜绿假单胞菌、肺炎克雷伯菌、鲍氏不动杆菌、副流感嗜血菌多见,分别占17.9%、13.3%、9.3%、8.1%;革兰阳性球菌347株占36.8%,以肺炎链球菌、表皮葡萄球菌、金黄色葡萄球菌多见,分别占12.6%、8.2%、7.1%;主要革兰阴性杆菌对头孢呋辛、氨苄西林、磺胺甲噁唑/甲氧苄啶耐药现象较为严重,对亚胺培南、美罗培南较为敏感;革兰阳性球菌对青霉素G、苯唑西林耐药比较严重,对利奈唑胺、万古霉素则比较敏感。结论根据药敏试验选择敏感抗菌药物联合用药,对下呼吸道感染治疗效果及临床耐药菌株的减少有重要的临床意义。 OBJECTIVE To observe the characteristics of distribution of pathogens causing lower respiratory tract infections in children and analyze the drug resistance so as to provide guidance for reasonable clinical use of antibiotics. METHODS Totally 3684 children with lower respiratory tract infections who were hospitalized from Jan 2008 to Dec 2012 were recruited in the study, then the results of sputum culture and drug susceptibility testing were retrospectively analyzed, the bacterial identification was conducted with the use of VITEK-2 automatic microorganism identification system, the drug susceptibility testing was performed by using the drug susceptibility card, and the obtained data were statistically analyzed by means of the WHO-NET5. 4 microbiological laboratory data processing software. RESULTS Of the 3684 children with lower respiratory tract infections, 943 cases were with sputum cultured positive with the positive rate of 25.6%. A total of 596 (63.2%) strains of gram-negative bacilli have been isolated, among which Pseudomonas aeruginosa (17. 9 %), Klebsiella pneumoniae (13. 3 %) , Acinetobacter baumannii (9. 3 %), and Haemophilus parainJluenzae (8. 1 %) were the predominant species; totally 347 (36.8%) strains of gram-positive cocci have been isolated, among which the Staphylococcus aureus (12. 6 %), Staphylococcus epidermidis (8. 2 %), and Streptococcus pneumoniae (7. 1 %) were dominant. The main gram-negative bacilli were highly resistant to cefoxitin, ampicillin, and sulfamethoxazole-trimethoprim and susceptible to imipenem and meropenern , the gram-positive cocci were highly resistant to penicillin G and oxacillin and susceptible to vancomycin and teicoplanin. CONCLUSION It is of great clinical significance in the therapeutic effect of lower respiratory tract infections and reduction of drug resistant strains to choose susceptible antibiotics based on the result of drug susceptibility testing.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2014年第5期1260-1262,共3页 Chinese Journal of Nosocomiology
基金 天津市卫生局科技基金项目(09KZ32)
关键词 下呼吸道感染 痰培养 药敏试验 病原菌 耐药性 Lower respiratory tract infection Sputum culture Drug susceptibility testing Pathogen Drug resistance
  • 相关文献

参考文献5

二级参考文献25

  • 1代洪,范学工.金黄色葡萄球菌对万古霉素耐药情况调查[J].临床检验杂志,2005,23(4):259-262. 被引量:14
  • 2王辉,孙宏莉,宁永忠,杨启文,陈民钧,朱元珏,徐英春,谢秀丽.不动杆菌属多重耐药及泛耐药的分子机制研究[J].中华医学杂志,2006,86(1):17-22. 被引量:183
  • 3赵永新.下呼吸道感染病原菌的分布及耐药性的分析[J].中国抗生素杂志,2006,31(3):190-192. 被引量:28
  • 4Wang H,Chen M,Ni Y,et al.Antimicrobial resistance analysis among nosocomial gram-negative bacilli from 10 teaching hospitals in China[J].Clin Lab Med,2005,28(12):1295-1303.
  • 5Levin AS,Barone AA,Penco J,et al.Intravenous colistin as therapy for nosocomial infections caused by multi-drug resistance pseudomonas aeruginosa and acinetlbacter baumannii[J].Clin Infect Dis,1999,28(5):1008-1011.
  • 6Clinical and Laboratory Standards Institute/NCCLS.Performance standards for antimicrobial susceptiblity testing;Fifteenth informational supplement.CLSI/NCCLS document MIO0-S15[J].Clinical and Laboratory Standards Institute,Wayne,Pennsylvania,2005,25(1):10-155.
  • 7Appelbaum PC.The emergence of vancomycirr intermediate and vancomycin resistant staphylococcus aureus[J].Clin Microbiol Infect,2006,12(1):16-19.
  • 8YANG T,HE Y L.Analysis of prophylactic application of antibiotics in 100 children in a perioperative period[J].Clin Pharmacoepidemiol,2007,16(5):304-306.
  • 9YuY S,Du X X,Zhou Z H,et al.Firstisolation of blaIMP2 in an Enterobacter cloacae clinical isolate from China.A ntimicrob A ngents Chemother,2006,50(4):1610-1611.
  • 10CLSI.Performance standards for a'ntimicrobial susceptibility testing;seventeenth informational supplement (M100S17),2007.

共引文献346

同被引文献171

引证文献20

二级引证文献188

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部